Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission
Ilaria S. Pagani(South Australian Health and Medical Research Institute), David M. Ross(Flinders Medical Centre), Randall Grose(South Australian Health and Medical Research Institute), Lisa Carne(Royal Adelaide Hospital), Deborah L. White(ANZCHOG), Haley Altamura(South Australia Pathology), Naranie Shanmuganathan(South Australia Pathology), Zandy Rwodzi(Royal Adelaide Hospital), Jodi Braley(South Australia Pathology), Timothy P. Hughes(Royal Adelaide Hospital), Jennifer McLean(South Australian Health and Medical Research Institute), Chung Hoow Kok(South Australian Health and Medical Research Institute), Sophie Watts(South Australian Health and Medical Research Institute), Verity A Saunders(South Australia Pathology), Agnes S. M. Yong(South Australia Pathology), David T Yeung(Royal Adelaide Hospital), Phuong Dang(South Australia Pathology), Susan Branford(South Australia Pathology)
Cited by 51
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464